Выбор темы
Выбор стиля шрифта
Pfizer новости
27/06
💡
МНЕНИЕ: Акции Pfizer под давлением из-за неудачи с новым препаратом - Синара
14/03
💡
МНЕНИЕ: Сделка по покупке Seagen окажет умеренно негативное влияние на акции Pfizer - Синара
29/08
💡
МНЕНИЕ: Иск со стороны Moderna представляет угрозу для Pfizer - Синара
09/06
PFE - Сделка Инсайдера: продажа 07 июня 2022
26/05
💡
МНЕНИЕ: Вспышка оспы обезьян привлекла внимание к рынку вакцин - Фридом Финанс
18/05
PFE - Сделка Инсайдера: продажа 16 мая 2022
17/05
PFE - Сделка Инсайдера: продажа 13 мая 2022
14/05
PFE - Сделка Инсайдера: продажа 12 мая 2022
14/05
PFE - Сделка Инсайдера: продажа 12 мая 2022
13/05
PFE - Сделка Инсайдера: продажа 11 мая 2022
11/05
💡
МНЕНИЕ: Pfizer: поможет ли лекарство от мигрени? - Синара
09/02
💡
МНЕНИЕ: Инвесторы спаведливо оценили отчетность Pfizer- Синара
02/02
🔗
Zacks Investment Research: Is a Beat Likely for Pfizer (PFE) This Earnings Season?
02/02
🔗
Benzinga: FDA Asks Pfizer - BioNTech To Submit For COVID-19 Vaccine Emergency Use Nod For Youngest Children
02/02
🔗
Pulse2: Pfizer (PFE) Stock: Why The Price Went Up
02/02
🔗
Yahoo Finance: COVID-19: Pfizer vaccine for kids under 5 ‘really good news,' doctor says
02/02
🔗
Market Watch: Pfizer asks FDA to OK COVID vaccines for children under 5
02/02
🔗
Forbes: Pfizer Asks FDA To Authorize Its Covid Shot For Kids Under 5
02/02
🔗
CNBC: Pfizer starts submitting data for FDA emergency approval of vaccine for kids under 5
01/02
🔗
The Motley Fool: What This FDA News Could Mean for Pfizer
01/02
🔗
Yahoo Finance: Coronavirus vaccine for children: Pfizer to seek authorization for vaccine for kids under 5
01/02
🔗
Market Watch: Pfizer may seek FDA's OK for COVID vaccine for kids under 5 as soon as Tuesday: reports
01/02
🔗
Benzinga: Pfizer Could Seek COVID-19 Vaccine Emergency Approval For Children Under 5 This Week
31/01
🔗
The Motley Fool: Why Pfizer Stock Is Sliding Today
31/01
🔗
Zacks Investment Research: Pfizer (PFE) Lorviqua Gets EU Nod for First-Line Lung Cancer
31/01
🔗
Seeking Alpha: Pfizer: Long COVID And Vaccination
29/01
🔗
The Motley Fool: Is This a Smart Deal for Pfizer?
28/01
🔗
The Motley Fool: Is Pfizer About to Have Another Megablockbuster Drug in Its Lineup?
27/01
🔗
Zacks Investment Research: Pfizer (PFE), BioNTech Begin Omicron-Based COVID-19 Jab Study
27/01
🔗
GuruFocus: Kahn Brothers' Top-Performing Stocks of 2021
26/01
🔗
The Motley Fool: 2 Stocks to Buy No Matter What Happens in 2022
26/01
🔗
Zacks Investment Research: Pfizer (PFE) Gains As Market Dips: What You Should Know
25/01
🔗
Proactive Investors: Pfizer and BioNTech set to begin trials of Omicron specific vaccine
25/01
🔗
Fox Business: Pfizer, BioNTech begin omicron-specific COVID-19 vaccine study
25/01
🔗
Forbes: Clinical Trials Begin For Pfizer And BioNTech's Omicron-Specific Covid Shot
25/01
🔗
Market Watch: Pfizer and BioNTech launch study to evaluate omicron-based COVID-19 vaccine for adults 18 to 55 years old
25/01
🔗
CNBC: Pfizer and BioNTech launch clinical study of Covid vaccine targeting omicron
25/01
🔗
The Motley Fool: Here's What to Look For in Pfizer's Upcoming Earnings Report
24/01
📉
Основные поставщики вакцин падают на 40% с начала января
24/01
🔗
Zacks Investment Research: Pfizer's (PFE), OPKO's BLA for Somatrogon Gets CRL From FDA
24/01
🔗
The Motley Fool: Should You Invest in Pfizer in 2022?
21/01
🔗
Seeking Alpha: 4 Upcoming Dividend Increases Including A King
20/01
🔗
Benzinga: Sputnik V Associated With Higher Antibody Levels Against Omicron Than Pfizer, Study Shows: Reuters
20/01
🔗
Forbes: Pfizer Covid Vaccine For Kids Under 5 Could Be Authorized In The Next Month, Fauci Says
20/01
🔗
CNBC: Fauci says FDA could authorize Pfizer's Covid vaccine for kids under 5 in the next month
19/01
🔗
Zacks Investment Research: Will 2022 Be a Better Year for Biotech Than 2021? 3 Big Picks
19/01
🔗
Seeking Alpha: Pfizer's Partnership With Beam Therapeutics About Becoming Global Leader In mRNA/Gene Therapy
19/01
🔗
Forbes: Pfizer Says Its Covid Antiviral Pill Is Effective Against Omicron Variant
18/01
🔗
Zacks Investment Research: Arena (ARNA) Stock Up in 6 Months on PFE Merger Deal & Pipeline
18/01
🔗
Fox Business: Pfizer COVID-19 pill approved in Canada
18/01
🔗
Benzinga: Pfizer To Boost Output For COVID-19 Oral Treatment With Novasep Deal
18/01
🔗
Benzinga: 4 Shots Of Pfizer COVID-19 Vaccine Not Enough To Prevent Omicron Infection, Say Israeli Researchers
17/01
🔗
Zacks Investment Research: Pfizer's (PFE) Cibinqo Gets FDA Nod for Atopic Dermatitis
16/01
🔗
GuruFocus: 3 Stocks With Double-Digit Return Potential
16/01
🔗
The Motley Fool: How Do Pfizer's and Merck's COVID Pills Work?
15/01
🔗
Yahoo Finance: Pfizer CEO says Omicron vaccine will be ready in March
14/01
🔗
The Motley Fool: Why Pfizer and BioNTech Got Thrashed on Thursday
13/01
🔗
Seeking Alpha: Pfizer And COVID: The Vaccine And Treatment Opportunities Are Still Underappreciated
13/01
🔗
Zacks Investment Research: Pfizer's (PFE) Prevnar 20 Plus COVID Vaccine Study Succeeds
12/01
🔗
The Motley Fool: Will Pfizer Hit $100 This Year?
12/01
🔗
The Motley Fool: 3 Growth Stocks That Have Generated $179 Billion in Free Cash Flow in 12 Months
11/01
🔗
Reuters: Exclusive-Pfizer to cut U.S. sales staff as meetings with healthcare providers move to virtual
11/01
🔗
Yahoo Finance: Omicron-specific vaccines are ‘already priced into COVID stocks': Jefferies Managing Director
11/01
🔗
Zacks Investment Research: Best Growth Stocks to Buy for January 11th
11/01
🔗
Market Watch: Pfizer plans to ready hybrid shot to protect against omicron by March, says CEO Bourla
11/01
🔗
Seeking Alpha: Pfizer Inc. (PFE) Management Presents at 40th Annual J.P. Morgan Healthcare Conference (Transcript)
11/01
🔗
CNBC: Pfizer CEO says two Covid vaccine doses aren't 'enough for omicron'
11/01
🔗
Forbes: Chile Latest Country To Roll Out 4th Covid Vaccine Shots — But Pfizer CEO Still Unsure Whether They're Necessary
10/01
🔗
Zacks Investment Research: Why the Earnings Surprise Streak Could Continue for Pfizer (PFE)
10/01
💡
МНЕНИЕ: Pfizer покорит новый рубеж - Финам
10/01
🔗
Business Insider: Exclusive: Pfizer plans to start human studies of its Omicron-specific COVID-19 vaccine before the end of January
10/01
🔗
Yahoo Finance: Pfizer CEO: New COVID-19 vaccine that covers Omicron ‘will be ready in March'
10/01
🔗
Forbes: Pfizer Bets Big On mRNA: New Deals Include $1.3 Billion Collaboration With Beam
10/01
🔗
Zacks Investment Research: 4 Lucrative Bets Boasting High Earnings Yield
10/01
🔗
CNBC Television: Pfizer CEO Bourla: Omicron-specific Covid vaccine will be ready by March
10/01
Вакцина от варианта Омикрон будет готова в марте — CEO Pfizer
10/01
🔗
CNBC: Pfizer CEO says omicron vaccine will be ready in March
10/01
🔗
Market Watch: Pfizer announces deal worth up to $1.3 billion with Beam; Beam's stock is up 4.9%
10/01
🔗
Benzinga: Pfizer, Beam Ink Multi-Target Research Collaboration For In Vivo Base Editing Programs
08/01
🔗
The Motley Fool: 3 COVID Stocks That Will Make Billions in 2022
07/01
🔗
CNBC: Pfizer Covid vaccine protects adolescents against multisystem inflammatory syndrome, CDC says
07/01
🔗
Seeking Alpha: How Will Pfizer's Covid-19 Pill Approval Impact Their Stock Forecast?
06/01
🔗
Seeking Alpha: Pfizer Inc. (PFE) CEO Dr. Albert Bourla Presents at Goldman Sachs 14th Annual Healthcare CEOs Unscripted Conference (Transcript)
06/01
🔗
Yahoo Finance: White House doubles order of Pfizer COVID-19 pills
06/01
🔗
Seeking Alpha: Pfizer's Codex DNA Deal Hints At Lucrative Pivot To mRNA - Keep An Eye On This Space
06/01
🔗
Zacks Investment Research: How to Select Stocks During Volatile Market Periods
06/01
🔗
Zacks Investment Research: Pfizer and BioNTech to Make mRNA-Based Shingles Vaccine
06/01
🔗
GuruFocus: Covid Jab Will Help Make Pfizer Top Drug Company in 2022
06/01
🔗
CNBC International TV: Mumbai's municipal commissioner: I don't think we need Pfizer vaccines right now
06/01
🔗
CNBC Television: Bank of America senior analyst explains why he's bearish on Moderna compared to Pfizer
06/01
🔗
Forbes: CDC Panel Recommends Pfizer Covid Vaccine Boosters For Ages 12-15
06/01
🔗
CNBC: CDC panel recommends Pfizer boosters for 12- to 15-year-olds amid omicron surge
05/01
🔗
Market Watch: Pfizer upgraded to buy at BofA as Paxlovid likely to offset patent expiration concerns
05/01
🔗
Benzinga: Why This Pfizer, Regeneron Analyst Has Contrasting Recommendations For The COVID Stock Plays
05/01
🔗
Zacks Investment Research: Best Growth Stocks to Buy for January 5th
05/01
🔗
CNBC Television: There's absolutely Covid stock fatigue, says Jefferies' Michael Yee
05/01
🔗
CNBC Television: U.S. to double order of Pfizer's antiviral Covid pill
04/01
🔗
Reuters: U.S. court revives lawsuit against Pfizer, others on Iraq terrorism funding claims
04/01
🔗
CNBC: Biden doubles U.S. order of Pfizer Covid treatment pills, speeds delivery as omicron rages across nation
04/01
🔗
Zacks Investment Research: PFE vs. RHHBY: Which Stock Should Value Investors Buy Now?
Загрузить еще